Topic: Viking Therapeutics

The pharmaceutical industry is bracing for potential price negotiations under the Inflation Reduction Act, with some analysts suggesting Donald Trump's proposals could be more disruptive to the industry than Joe Biden's. Meanwhile, Viking Therapeutics has emerged as a major competitor in the weight loss drug market, reporting positive results from clinical trials. The discussion highlights the lack of focus on diet and lifestyle in the national conversation about obesity.